CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale Chief Accounting Officer sold 215 shares at an average $1.25 ($268)
- 4 Open-market sale Chief Development Officer sold 435 shares at an average $1.25 ($543)
- 4 Open-market sale Chief Commercial Officer sold 469 shares at an average $1.25 ($585)
- 4 Open-market sale President & CEO sold 3,765 shares at an average $1.25 ($4,699)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 982 shares at an average $1.25 ($1,226)
- 4 Open-market buy Director bought 128,363 shares at an average $1.69 ($216,510)
- 4 Grant or award Director acquired 9,989,506 shares (grant or award)
- 4 Open-market sale Chief Accounting Officer sold 559 shares at an average $1.33 ($742)
- 4 Open-market sale Chief Development Officer sold 1,573 shares at an average $1.33 ($2,088)
- 4 Open-market sale Chief Commercial Officer sold 1,699 shares at an average $1.33 ($2,256)
- 4 Open-market sale President & CEO sold 13,782 shares at an average $1.33 ($18,297)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 3,577 shares at an average $1.33 ($4,749)
- 4 Grant or award Director acquired 12,345 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 617 shares (grant or award)
- 4 Grant or award Director acquired 308,640 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 617 shares (grant or award)
- 4 Grant or award Director acquired 61,728 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 6,172 shares (grant or award)
- 4 Grant or award Director acquired 30,864 shares (grant or award)
- 4 Grant or award Director acquired 6,172,839 shares (grant or award)
Page 8 of 17 · 336 filings